Journal of Surgical Research
Volume 146, Issue 2 , Pages 184-189 , 15 May 2008

Colchicine Inhibits Intimal Hyperplasia and Leukocyte VEGF Expression in Dogs

  • Hussein M. Atta, M.D.

      Affiliations

    • Department of Surgery, Faculty of Medicine, Minia University, El-Minia, Egypt
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Department of Surgery, Faculty of Medicine, Minia University, El-Minia 61111, Egypt.
    • ,
  • Mahmoud A. El-Rehany, M.D.

      Affiliations

    • Department of Biochemistry, Faculty of Medicine, Minia University, El-Minia, Egypt
    • ,
  • Salama R. Abdel Raheim, M.D.

      Affiliations

    • Department of Biochemistry, Faculty of Medicine, Minia University, El-Minia, Egypt
    • ,
  • Rasha Fouad, M.B., B.Ch.

      Affiliations

    • Department of Biochemistry, Faculty of Medicine, Minia University, El-Minia, Egypt
    • ,
  • Abdel Moneim F. Galal, M.D.

      Affiliations

    • Department of Biochemistry, Faculty of Medicine, Minia University, El-Minia, Egypt

Received 13 February 2007

References 

  1. Tegtmeyer CJ, Hartwell GD, Selby JB, et al. Results and complications of angioplasty in aortoiliac disease. Circulation. 1991;83(2 Suppl):I53
  2. Beatt KJ, Serruys PW, Luijten HE, et al. Restenosis after coronary angioplasty: The paradox of increased lumen diameter and restenosis. J Am Coll Cardiol. 1992;19:258
  3. Stansby G, Chan YC, Berwanger CS, et al. Prevention of experimental myointimal hyperplasia by immunomodulation. Eur J Vasc Endovasc Surg. 2002;23:23
  4. Welt FGP, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 2002;22:1769
  5. Roque M, Fallon JT, Badimon JJ, et al. Mouse model of femoral artery denudation injury associated with rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol. 2000;20:335
  6. Gaudry M, Bregerie O, Andrieu V, et al. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood. 1997;90:4153
  7. Lee MS, David EM, Makkar RR, et al. Molecular and cellular basis of restenosis after percutaneous coronary intervention: The intertwining roles of platelets, leukocytes, and the coagulation-fibrinolysis system. J Pathol. 2004;203:861
  8. Ludemann J, Schulte KL, Hader O, et al. Leukocyte/endothelium activation and interactions during femoral percutaneous transluminal angioplasty. Vasc Surg. 2001;35:293
  9. Bauriedel G, Heimerl J, Beinert T, et al. Colchicine antagonizes the activity of human smooth muscle cells cultivated from arteriosclerotic lesions after atherectomy. Coron Artery Dis. 1994;5:531
  10. March KL, Mohanraj S, Ho PP, et al. Biodegradable microspheres containing a colchicine analogue inhibit DNA synthesis in vascular smooth muscle cells. Circulation. 1994;89:1929
  11. Voisard R, Seitzer U, Baur R, et al. A prescreening system for potential antiproliferative agents: Implications for local treatment strategies of postangioplasty restenosis. Int J Cardiol. 1995;51:15
  12. Giannakakou P, Nakano M, Nicolaou KC, et al. Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc Natl Acad Sci USA. 2002;99:10855
  13. Cowan CR, Cande WZ. Meiotic telomere clustering is inhibited by colchicine but does not require cytoplasmic microtubules. J Cell Sci. 2002;115:3747
  14. Currier JW, Pow TK, Minihan AC, et al. Colchicine inhibits restenosis after iliac angioplasty in the atherosclerotic rabbit. (Abstr) Circulation. 1989;80(suppl II, part 2):66
  15. O'Keefe JH, McCallister B, Bateman TM, et al. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol. 1992;19:1597
  16. Muller DW, Ellis SG, Topol EJ. Colchicine and antineoplastic therapy for the prevention of restenosis after percutaneous coronary interventions. J Am Coll Cardiol. 1991;17:126B
  17. Gradus-Pizlo I, Wilensky RL, March KL, et al. Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: Effects on restenosis and implications for catheter-based drug delivery. J Am Coll Cardiol. 1995;26:1549
  18. Geary RL, Nikkari ST, Wagner WD, et al. Wound healing: A paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg. 1998;27:96
  19. Yasuda S, Noguchi T, Gohda M, et al. Single low-dose administration of human recombinant hepatocyte growth factor attenuates intimal hyperplasia in a balloon-injured rabbit iliac artery model. Circulation. 2000;101:2546
  20. Li C, Yang CW, Ahn HJ, et al. Colchicine suppresses osteopontin expression and inflammatory cell infiltration in chronic cyclosporine nephrotoxicity. Nephron. 2002;92:422
  21. Addrizzo-Harris DJ, Harkin TJ, Tchou-Wong KM, et al. Mechanisms of colchicine effect in the treatment of asbestosis and idiopathic pulmonary fibrosis. Lung. 2002;180:61
  22. Cuschieri J, Gourlay D, Garcia I, et al. Modulation of endotoxin-induced endothelial activity by microtubule depolymerization. J Trauma. 2003;54:104
  23. Bhardwaj S, Roy H, Heikura T, et al. VEGF-A, VEGF-D, and VEGF-DΔNΔC induced intimal hyperplasia in carotid arteries. Eur J Clin Invest. 2005;35:669
  24. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol. 1997;17:2238
  25. Carmeliet P, Moons L, Stassen J-M, et al. Vascular wound healing and neointima formation induced by perivascular electric injury in mice. Am J Pathol. 1997;150:761
  26. Moroi M, Zhang L, Yasuda T, et al. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest. 1998;101:1225
  27. Yasuda S, Noguchi T, Gohda M, et al. Local delivery of low-dose docetaxel, a novel microtubule polymerizing agent, reduces neointimal hyperplasia in balloon-injured rabbit iliac artery model. Cardiovasc Res. 2002;53:481
  28. Southern FN, Cruz N, Fink LM, et al. Hyperhomocysteinemia increases intimal hyperplasia in a rat endarterectomy model. J Vasc Surg. 1998;28:909
  29. Kanamasa K, Narutaka O, Ishida N, et al. A 7-day administration of TPA or heparin in the prevention of intimal hyperplasia following vascular injury in atherosclerotic rabbits. J Interven Cardiol. 2002;15:191
  30. Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation. 2005;111:2257
  31. Shah PK. Inflammation, neointimal hyperplasia, and restenosis (As the leukocytes roll, the arteries thicken). Circulation. 2003;107:2175
  32. Zeiffer U, Schober A, Lietz M, et al. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines. Circ Res. 2004;94:776
  33. Kitamoto S, Egashira K, Takeshita A. Stress and vascular responses: Anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention. J Pharmacol Sci. 2003;91:192
  34. Rogers C, Edelman ER, Simon DI. A mAB to the b2-leukocyte integrin Mac-1 (CD11byCD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci. USA. 1998;95:10134
  35. Zhou Z, Penn MS, Forudi F, et al. Administration of recombinant P-selectin glycoprotein ligand Fc fusion protein suppresses inflammation and neointimal formation in Zucker diabetic rat model. Arterioscler Thromb Vasc Biol. 2002;22:1598
  36. Zhao Q, Egashira K, Hiasa K, et al. Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury. Arterioscler Thromb Vasc Biol. 2004;24:2284
  37. Ruef J, Hu ZY, Yin LY, et al. Induction of vascular endothelial growth factor in balloon-injured baboon arteries (A novel role for reactive oxygen species in atherosclerosis). Circ Res. 1997;81:24
  38. Ishida A, Murray J, Saito Y, et al. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol. 2001;188:359
  39. Khurana R, Zhuang Z, Bhardwaj S, et al. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation. 2004;110:2436
  40. Koehne P, Willam C, Strauss E, et al. Lack of hypoxic stimulation of VEGF secretion from neutrophils and platelets. Am J Physiol Heart Circ Physiol. 2000;279:H817
  41. Chung JK, Lee T, Jung IM, et al. Expression of cell cycle regulators during smooth muscle cell proliferation after balloon catheter injury of rat artery. J Korean Med Sci. 2004;19:324
  42. Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression (New therapeutic target for vascular proliferative disease). Circulation. 1998;98:82
  43. Taylor AM, McNamara CA. Regulation of vascular smooth muscle cell growth (Targeting the final common pathway). Arterioscler Thromb Vasc Biol. 2003;23:1717
  44. Axel DI, Kunert W, Goggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96:636
  45. Friedkin M, Legg A, Rozengurt E. Enhancement of DNA synthesis by colchicine in 3T3 mouse fibroblasts stimulated with growth factors. Exp Cell Res. 1980;129:23
  46. East MA, Landis DI, Thompson MA, et al. Effect of single dose of intravenous heparin on plasma levels of angiogenic growth factors. Am J Cardiol. 2003;91:1234
  47. Ellis SG, Roubin GS, Wilentz J, et al. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 1989;117:777
  48. Gimple LW, Gertz SD, Haber HL, et al. Effect of chronic subcutaneous or intramural administration of heparin on femoral artery restenosis after balloon angioplasty in hypercholesterolemic rabbits: A quantitative angiographic and histopathological study. Circulation. 1992;86:1536

PII: S0022-4804(07)00321-6

doi: 10.1016/j.jss.2007.04.029

Journal of Surgical Research
Volume 146, Issue 2 , Pages 184-189 , 15 May 2008

Article Tools

* Image Usage & Resolution